Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors
Clinical trial NCT01343498 · COMPLETED
Trial details
- NCT number
- NCT01343498
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2014-01-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.